ZMB Member Bernd Giebel
ZMB Member
Bernd Giebel
Next ZMB-Member
Prof. Dr. Bernd Giebel
Institute for Transfusion Medicine
University Hospital Essen
Hufelandstraße 55
45122 Essen
- +49 201 723 4204
- Website
- Press Releases
- Selected Publications
- Publication Metrics
-
- ZMB Research Program
Immunology, Infectious Diseases and Transplantation
Research Overview
The group of Bernd Giebel investigates lineage relationships of early human hematopoietic progenitors as well as mechanisms controlling their self-renewal and lineage specification. In this context the group is especially interested in dissecting roles of asymmetric cell division, which they have proven to occur in at least a proportion of the cells. Since 2009, as a second topic the group is also working in the fast expanding field of extracellular vesicles (EVs), often termed exosomes or microvesicles, respectively. Here, the group is especially interested in deciphering the therapeutic potential of EVs released from mesenchymal stem/stromal cells (MSCs). After demonstrating therapeutic potentials in different systems including the treatment of a graft-versus-host disease patient, the group now aims to optimize and qualify the MSC-EV production for the clinical setting.
Keywords: Hematopoietic stem cells, hematopoiesis, mesenchymal stem cells, extracellular vesicles, exosomes
Read more
Selected Publications
-
Acute respiratory distress vs healthy lung environments differently affect mesenchymal stromal cell extracellular vesicle miRNAsIn: Cytotherapy , Vol. 27 2025 , Nr. 5 , pp. 581 - 596DOI (Open Access)
-
Overcoming challenges in MSC-sEV therapeutics : Insights and advances after a decade of researchIn: Cytotherapy 2025 , in pressDOI (Open Access)
-
Calcium chloride declotted human platelet lysate promotes the expansion of mesenchymal stromal cells and allows manufacturing of immunomodulatory active extracellular vesicle productsIn: Cytotherapy , Vol. 26 2024 , Nr. 9 , pp. 988 - 998DOI (Open Access)
-
Process development for the production of mesenchymal stromal cell-derived extracellular vesicles in conventional 2D systemsIn: Cytotherapy , Vol. 26 2024 , Nr. 9 , pp. 999 - 1012DOI (Open Access)
-
A report on the International Society for Cell & Gene Therapy 2022 Scientific Signature Series, “Therapeutic advances with native and engineered human extracellular vesicles”In: Cytotherapy , Vol. 25 2023 , Nr. 8 , pp. 810 - 814
-
CD73 activity of mesenchymal stromal cell-derived extracellular vesicle preparations is detergent-resistant and does not correlate with immunomodulatory capabilitiesIn: Cytotherapy , Vol. 25 2023 , Nr. 2 , pp. 138 - 147DOI (Open Access)
-
Independent human mesenchymal stromal cell–derived extracellular vesicle preparations differentially attenuate symptoms in an advanced murine graft-versus-host disease modelIn: Cytotherapy 2023DOI (Open Access)
-
Qualification of a multidonor mixed lymphocyte reaction assay for the functional characterization of immunomodulatory extracellular vesiclesIn: Cytotherapy , Vol. 25 2023 , Nr. 8 , pp. 847 - 857
-
Imaging flow cytometry challenges the usefulness of classically used extracellular vesicle labeling dyes and qualifies the novel dye Exoria for the labeling of mesenchymal stromal cell–extracellular vesicle preparationsIn: Cytotherapy , Vol. 24 2022 , Nr. 6 , pp. 619 - 628DOI (Open Access)
-
Postischemic Neuroprotection Associated With Anti-Inflammatory Effects by Mesenchymal Stromal Cell-Derived Small Extracellular Vesicles in Aged MiceIn: Stroke , Vol. 53 2022 , Nr. 1 , pp. E14 - E18DOI (Open Access)
-
Circulating MicroRNAs : Posttranscriptional Regulators and Disease Markers Holding Promise in Stroke PredictionIn: Stroke , Vol. 52 2021 , Nr. 3 , pp. 954 - 956DOI (Open Access)
-
Critical considerations for the development of potency tests for therapeutic applications of mesenchymal stromal cell-derived small extracellular vesiclesIn: Cytotherapy , Vol. 23 2021 , Nr. 5 , pp. 373 - 380DOI (Open Access)
-
Impact of mesenchymal stromal/stem cell isolation strategies on the immunomodulatory activity of their extracellular vesiclesIn: Cytotherapy , Vol. 23 2021 , Nr. Suppl. 5 , pp. 113
-
New Light on the Horizon : Extracellular Vesicles as Diagnostic Tool in Transient Ischemic Attack and Ischemic StrokeIn: Stroke , Vol. 52 2021 , Nr. 10 , pp. 3348 - 3350DOI (Open Access)
-
International Society for Extracellular Vesicles and International Society for Cell and Gene Therapy statement on extracellular vesicles from mesenchymal stromal cells and other cells : considerations for potential therapeutic agents to suppress coronavirus disease-19In: Cytotherapy , Vol. 22 2020 , Nr. 9 , pp. 482 - 485DOI (Open Access)
-
Mesenchymal Stromal Cell-Derived Small Extracellular Vesicles Induce Ischemic Neuroprotection by Modulating Leukocytes and Specifically NeutrophilsIn: Stroke , Vol. 9 2020 , Nr. 10 , pp. 1825 - 1834DOI (Open Access)
-
Ultrasmall gold nanoparticles (2 nm) can penetrate and enter cell nuclei in an in vitro 3D brain spheroid modelIn: Acta Biomaterialia , Vol. 111 2020 , pp. 349 - 362
-
A mixed lymphocyte reaction as a functional assay for extracellular vesicles of different originsIn: Cytotherapy , Vol. 21 2019 , Nr. 5 , pp. 57
-
Free flow electrophoresis allows preparation of extracellular vesicles with high purityIn: Cytotherapy , Vol. 21 2019 , Nr. Suppl. 5 , pp. 57 - S58
-
MSC-EVS protect mice from graft-versus-host disease pathology in a preparation dependent mannerIn: Cytotherapy , Vol. 21 2019 , Nr. Suppl. 5 , pp. 57
-
Tangential flow filtration, a potential method for the scaled preparation of extracellular vesiclesIn: Cytotherapy , Vol. 21 2019 , Nr. Suppl. 5 , pp. 57
-
EV-TRACK : Transparent reporting and centralizing knowledge in extracellular vesicle researchIn: Nature Methods , Vol. 14 2017 , Nr. 3 , pp. 228 - 232
-
Breast cancer-derived extracellular vesicles : clinical and prognostic impactIn: Cancer Research , Vol. 76 2016 , Nr. 14 Suppl. , pp. 3152
-
Evidence-Based Clinical Use of Nanoscale Extracellular Vesicles in NanomedicineIn: ACS Nano , Vol. 10 2016 , Nr. 4 , pp. 3886 - 3899
-
GFI1 as a novel prognostic and therapeutic factor for AML/MDSIn: Leukemia , Vol. 30 2016 , Nr. 6 , pp. 1237 - 1245
-
CD133 allows elaborated discrimination and quantification of haematopoietic progenitor subsets in human haematopoietic stem cell transplantsIn: British Journal of Haematology , Vol. 169 2015 , Nr. 6 , pp. 868 - 878
-
Multipotent Hematopoietic Progenitors Divide Asymmetrically to Create Progenitors of the Lymphomyeloid and Erythromyeloid LineagesIn: Stem Cell Reports , Vol. 5 2015 , Nr. 1 , pp. 154 - 155DOI (Open Access)
-
Autologous bone marrow mononuclear cell therapy improves symptoms in patients with end-stage peripheral arterial disease and reduces inflammation-associated parametersIn: Cytotherapy , Vol. 16 2014 , Nr. 9 , pp. 1270 - 1279
-
Evaluation of human platelet lysate versus fetal bovine serum for culture of mesenchymal stromal cellsIn: Cytotherapy , Vol. 16 2014 , Nr. 2 , pp. 170 - 180
-
MSC-derived exosomes : a novel tool to treat therapy-refractory graft-versus-host diseaseIn: Leukemia , Vol. 28 2014 , Nr. 4 , pp. 970 - 973
-
Multipotent hematopoietic progenitors divide asymmetrically to create progenitors of the lymphomyeloid and erythromyeloid lineagesIn: Stem Cell Reports , Vol. 3 2014 , Nr. 6 , pp. 1058 - 1072DOI (Open Access)
-
Revision of the Human Hematopoietic Tree: Granulocyte Subtypes Derive from Distinct Hematopoietic LineagesIn: Cell Reports , Vol. 3 2013 , Nr. 5 , pp. 1539 - 1552
-
Vemurafenib reverses immunosuppression by myeloid derived suppressor cellsIn: Cancer Research , Vol. 73 2013 , Nr. 8 Suppl. , pp. 4714
-
Preclinical Testing of a Novel Axl-Kinase Inhibitor in Chronic Lymphocytic LeukemiaIn: Blood , Vol. 120 2012 , Nr. 21